Compare CPIX & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPIX | IINN |
|---|---|---|
| Founded | 1999 | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.1M | 35.3M |
| IPO Year | 2009 | 2021 |
| Metric | CPIX | IINN |
|---|---|---|
| Price | $2.57 | $1.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 92.6K | ★ 128.4K |
| Earning Date | 11-04-2025 | 10-01-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $41,278,349.00 | $289,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2,582.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.21 | N/A |
| 52 Week Low | $1.85 | $0.40 |
| 52 Week High | $7.25 | $1.65 |
| Indicator | CPIX | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 56.08 | 59.72 |
| Support Level | $2.11 | $1.03 |
| Resistance Level | $2.73 | $1.18 |
| Average True Range (ATR) | 0.23 | 0.06 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 72.60 | 84.94 |
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.